NeuroSense Therapeutics (NRSNW) Short Interest Ratio & Short Volume

Short interest is the volume of NeuroSense Therapeutics shares that have been sold short but have not yet been covered or closed out. As of September 30th, investors have sold 500 shares of NRSNW short. Learn More on NeuroSense Therapeutics' current short interest.

NeuroSense Therapeutics saw a decrease in short interest in September. As of September 30th, there was short interest totaling 500 shares, a decrease of 28.6% from the previous total of 700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to NeuroSense Therapeutics: Alvotech (0.07%), LAVA Therapeutics (0.13%), Mainz Biomed (8.71%), Pharvaris (0.76%), Procaps Group S.A. (0.11%), and

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.04 billion), AppLovin Co. ($2.69 billion), Nu Holdings Ltd. ($2.64 billion), Paychex, Inc. ($2.61 billion), Cencora, Inc. ($2.30 billion), Aptiv PLC ($2.09 billion), Moderna, Inc. ($2.09 billion), Tractor Supply ($2.04 billion), Coinbase Global, Inc. ($1.97 billion), and International Paper ($1.95 billion). View all of the most shorted stocks.

Short selling NRSNW is an investing strategy that aims to generate trading profit from NeuroSense Therapeutics as its price is falling. NRSNW shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for NeuroSense Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NRSNW, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRSNW, twice per month. The most recent reporting period available is September, 30 2024.